GlassScriptPhysician profile
John W Wilson
NPI 1982790010
$9,507.91
in general payments reported to CMS, 2019-2025
19 companies · $545 in 2025
The $545 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $375 · 2020: $5,848 · 2021: $118 · 2022: $1,218 · 2023: $495 · 2024: $909 · 2025: $545.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,493 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $300 · Travel and Lodging: $155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,493.36 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $300.00 |
| Travel and Lodging | $155.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,347.59 | 2019-2025 | Da Vinci Surgical System |
| Davol INC. | $155.74 | 2020-2023 | Phasix Mesh |
| 4web, INC. | $146.72 | 2023 | Spine Truss System |
| Nuvasive, INC. | $135.86 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $104.11 | 2021-2025 | Gattex |
| Tela Bio, INC. | $98.99 | 2023-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Covidien LP | $85.63 | 2019-2020 | |
| Baxter Healthcare | $85.35 | 2021-2025 | Tisseel |
| Solventum Corporation | $61.87 | 2024-2025 | Prevena, Abthera, Activ.A.C. |
| Ethicon US, LLC | $49.24 | 2020-2021 | |
| Smith+Nephew, INC. | $47.27 | 2024-2025 | Renasys Touch |
| Medtronic, INC. | $38.87 | 2023-2024 | Signia, Ligasure |
| Vertex Pharmaceuticals Incorporated | $32.50 | 2025 | |
| Dilon Technologies, INC. | $25.02 | 2025 | Hemoblast Bellows |
| Ossur Americas, INC. | $22.04 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baudax Bio INC. | $21.98 | 2020 | |
| Integra Lifesciences Corporation | $17.90 | 2024 | Integra, Omnigraft, Integra Dermal Regeneration Template |
| Myriad Genetic Laboratories, INC. | $15.80 | 2021 | |
| Allergan, INC. | $15.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.